Navigation Links
EasyOne Pro from ndd Medical Technologies Chosen Again as the Exclusive PFT Testing Technology in Phase 2 of COPDGene Study
Date:7/24/2014

ANDOVER, Mass., July 24, 2014 /PRNewswire/ -- ndd Medical Technologies, a leader in innovative mobile pulmonary function testing (PFT) employing precise ultrasound technology, announced that its EasyOne Pro® has been chosen as the instrument to measure Carbon Monoxide Diffusing Capacity (DLCO) for phase 2 of the COPDGene® Study, the most comprehensive study of Chronic Obstructive Pulmonary Disease (COPD) ever undertaken.  COPD is now the third leading cause of death in the U.S. and affects millions of people worldwide. 

In COPDGene phase 1, a multicenter, 10,000-patient study to identify genetic, epidemiological and radiological characteristics of COPD, ndd Medical's market-leading spirometry equipment, EasyOne® Plus, was used for all spirometry testing.  COPDGene phase 2 added the key test, DLCO, to measure aspects of the lung membrane and the ability of the lungs to oxygenate the blood.

"Spirometry, which has classically been used to measure, diagnose and manage COPD, may not be as accurate as previously thought," says Robert Jensen, Ph.D., head of the study's PFT Quality Assurance.   "The EasyOne Pro provides both DLCO and spirometry testing and is the only instrument incorporating molar mass measurement for very precise analysis." 

According to Jensen, investigators raised additional funds to purchase the EasyOne Pro at all 21 study centers.  The decision was made in part because of the "extraordinary stability" of its ultrasound measurement of volumes and flows, but also for its imperviousness to temperature, barometric pressure, altitude and other factors that can result in faulty measurements of DLCO and spirometry.

Among the goals of the COPDGene study, initially funded with a $37 million grant from the National Institutes of Health, is the understanding of genetic information that contributes or is associated with a person's risk for developing COPD, potentially leading to new therapeutic approaches to control the disease and improve quality of life for COPD patients. 

COPD is the umbrella term for a variety of progressive lung diseases— most commonly emphysema and chronic bronchitis— marked by damaged lung tissue, making it difficult to breathe.

About ndd Medical Technologies, Inc.

With 40 percent of the U.S. spirometry market share, ndd Medical Technologies offers innovative, easy-to-use pulmonary function testing instruments that help clinicians diagnose lung disease with greater precision for optimal treatment.  Its EasyOne® and EasyOne Pro® portable instruments take up just 12 inches of space to take lung function testing wherever it is needed, in the pulmonary function laboratory, at the bedside or in the field. ndd's devices measure DLCO, FRC, LCI and FVC with  their patented Ultrasonic TrueFlow™ technology, which requires no calibration, eliminates problems associated with traditional methods of flow measurement, making testing fast, reliable and error free.  To learn more, visit www.nddmed.com.


'/>"/>
SOURCE ndd Medical, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations ... Latin America . ... ... ... ...
(Date:6/23/2016)... 2016  Experian Health, the healthcare industry ... patient payment and care experience, today announced ... and services that will enhance the breadth ... These award-winning solutions will enable healthcare professionals ... in an ever-changing environment and redefine front-office ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best ... individuals in the United States and Canada wear eyeglasses. Once considered to be a ... and make a fashion statement. Even celebrities use glasses as a way of creating ...
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
Breaking Medicine News(10 mins):